Reports & Research
Billion-dollar Drug Company Nearly Squashes Astounding Research on Natural Cancer Killer
HEALTH SCIENCES INSTITUTE on GRAVIOLA
Members Alert for January 2001 Vol. 5, No 7
Colon and breast cancer conquered with miracle tree from the Amazon found to be 10,000 times stronger than chemotherapy. Since our inception in 1996, Health Sciences Institute has scoured the world to find cutting-edge treatments few people have access to or have even heard about. And sometimes, what we uncover startles even the medical mavericks on our board.
Two months ago, we learned about an astounding cancer-fighting tree from the Amazon that has literally sent shock waves through the HSI network.
Today, the future of cancer treatment and the chances of survival look more promising than ever. There's a healing tree that grows deep within the Amazon rain forest in South America that could literally change how you, your doctor, and possibly rest of the world think about curing cancer. With extracts from this powerful tree, it may now be possible to…
- conquer cancer safely and effectively with an all-natural therapy that doesn't cause extreme nausea, weight loss, and hair loss
- protect your immune system and evade deadly infections
- feel strong and healthy throughout the course of treatment
- boost your energy and improve your outlook on life.
Through a series of confidential communications involving a researcher from one of America's largest pharmaceutical companies, this ancient tree's anticancerous properties have recently come to light. Although not yet tested in human trials, the tree has been studied in more than 20 laboratory tests since the 1970s, where it's been shown to:
- effectively target and kill malignant cells in 12 different types of cancer, including colon, breast, prostate, lung, and pancreatic cancer
- be 10,000 times stronger in killing colon cancer cells than Adriamycin, a commonly used chemotherapeutic drug
- selectively hunt down and kill cancer cells without harming healthy cells, unlike chemotherapy
So why isn't every health publication extolling the benefits of this treatment? Why hasn't it been made widely available throughout the natural-medicine community? And, if it's only half as promising as it appears to be, why isn't every oncologist at every major hospital insisting on using it on all his patients? Especially when you consider that since the early 1990s, extensive independent research including research by one of today's leading drug companies and by the National Cancer Institute confirms that the tree's chemical extracts attack and destroy cancer cells with lethal precision.
The answer to these difficult questions can only be explained by recounting a disturbing story we recently uncovered. More than anything else we've reported on this year, the story of this Amazon cancer treatment reinforces the need for groups like HSI and illustrates how easily our options for medical treatment are controlled by money and power.
News of this amazing tree was nearly lost forever
A confidential source, whose account we've been able to independently confirm, revealed that a billion dollar drug company in the United States tried for nearly seven years to synthesize two of the tree's most powerful anticancerous chemicals. In the early 1990s, behind lock and key, this well-known drug giant began searching for a cure for cancer-- while preciously guarding their opportunity to patent it and, therefore, profit from it.
Research focused on a legendary healing tree called Graviola. Parts of the tree -- including the bark, leaves, roots, fruit and fruit seeds -- had been used for centuries by medicine men and native Indians in South American to treat heart disease, asthma, liver problems, and arthritis. Going on little documented scientific evidence, the company poured money and resources into testing Graviola's anticancerous properties--and they were shocked by the results. Graviola was a cancer-killing dynamo. But that's where the story of Graviola nearly ended.
The pharmaceutical company had a big problem. They'd spend years trying to isolate and create man-made duplicates of two of the tree's most powerful chemicals. But they'd hit a brick wall. They couldn't replicate the original. And they couldn't sell the tree extract itself profitably -- because federal law mandates that natural substances can't be patented. That meant the company couldn't protect its profits on the project it had poured millions of dollars and nearly seven years of research into.
As the dream of big profits
testing on Graviola came to a screeching halt.
After seven frustrating years and without the promise of lucrative sales, the company shelved the project and refused to publish its findings in an independent journal. But one responsible researcher struggled with the decision. While understanding the company's goal of profits, he couldn't accept the decision to hide this unique cancer killer from the world. Following his conscience and risking his career, he contacted Raintree Nutrition, a company dedicated to harvesting medical plants from the Amazon.
As a result, Raintree went into high gear and began to research related studies published on Graviola. They discovered that several other teams in the United States (in addition to that of the drug company) had been testing Graviola in vitro (in test tubes). The results supported the drug company's secret findings, Graviola had been shown to kill cancer cells.
Graviola hunts down and destroys
prostate, lung, breast,
colon, and pancreatic cancers… leaving healthy cells alone
Since November, we've been looking closely into the research to date on Graviola. It appears one of the first scientific references to it in the United States was by the National Cancer Institute (NCI). In 1976, the NCI included Graviola in a plant-screening program that showed its leaves and stems were effective in attacking and destroying malignant cells. But the results were part of an internal NCI report and were, for some reason, never released to public.
Since 1976, there have been several promising cancer studies on Graviola. However, the tree's extracts have yet to be tested on cancer patients. No double-blind clinical trials exist, and clinical trials are typically the benchmark mainstream doctors and journals use to judge a treatment's value. Nevertheless, Graviola has been shown to kill cancer cells in vitro in at least 20 laboratory tests that our research has uncovered.
The most recent study, conducted at Catholic University of South Korea earlier this year, revealed that two chemicals extracted from Graviola seeds showed "selective cytotoxicity comparable with Adriamycin" for breast and colon cancer cells. The chemicals targeted and killed malignant breast and colon cells in a test tube comparable to the commonly used chemotherapy drug Adriamycin.
Another study, published in the Journal of Natural Products, showed that Graviola is not only comparable to Adriamycin but dramatically outperforms it in laboratory tests. Results showed that one chemical found in Graviola selectively killed colon cancer cells at "10,000 times the potency of Adriamycin."
Other promising and ongoing research at Purdue University is supported by a grant from the National Cancer Institute. Purdue researchers recently found that leaves from the Graviola tree killed cancer cells "among six human-cell lines" and were especially effective against prostate and pancreatic cancer cells. In a separate study, Purdue researchers showed that extracts from the Graviola leaves are extremely effective in isolating and killing lung cancer cells.
Perhaps the most significant result of the study cited above from the Catholic University of South Korea, and of each of the others we ve found, is that Graviola was shown to selectively target the enemy leaving all healthy, normal cells untouched. By comparison, chemotherapy indiscriminately seeks and destroys all actively reproducing cells even normal hair and stomach cells. This is what causes such often devastating side effects as hair loss and severe nausea. In this respect, Graviola looks to be a promising alternative or supplement to mainstream treatments.
From a clinical standpoint, Graviola still has a long way to go. Its properties have only been studied in a test tube. That's why it has yet to become widely known and accepted.
Despite the mounting collection of laboratory tests and anecdotal reports about this cancer-fighting dynamo, Graviola may always remain an underground therapy!
Graviola has yet to be clinically tested on animals or humans. And because Graviola is a natural product, it can't be patented. Without the promise of exclusive sales and high profitability, it will likely never again draw the attention of a major drug company or research lab. So we may never see a double-blind clinical study on the tree that's reported to help defeat cancer.
But there's no doubt about it -- the early laboratory tests and anecdotal reports about Graviola are very exciting. And if you've been diagnosed with cancer, you and your doctor should look at all the available treatment options. Graviola may just provide the help you've been looking for that could make all the difference in beating cancer.
Graviola fights more than cancer: